Shareholder Alert: Class Action Lawsuit Against Alexion Announced by Holzer & Holzer

Shareholder Alert: Class Action Lawsuit Against Alexion Announced by Holzer & Holzer


The complaint alleges Alexion used unlawful sales practices with respect to Soliris during that time. According to the complaint, the Company's revenues attributable to Soliris sales were unsustainable as a result.



from Biotech News